OTC:ENDV | Free Cash Flow | ENDONOVO THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2023-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2023-03-31-$173,156.00
2022-12-31-$225,541.00
2022-03-31-$122,954.00
2021-12-31-$391,296.00
2021-03-31-$289,948.00
2020-12-31-$192,856.00
2020-03-31-$297,215.00
2019-12-31-$308,381.00$0.00-$308,381.00
2019-03-31-$528,233.00
2018-12-31-$716,095.00$0.00-$716,095.00-51.81%
2018-03-31-$590,751.00$8,969.00-$599,720.00
2017-12-31-$800,574.00
2017-03-31-$434,192.00
2016-12-31-$658,650.00
2016-03-31-$424,869.00
2015-12-31-$211,289.00
2015-03-31-$193,836.00
2014-12-31-$227,734.00
2014-03-31-$195,930.00
2013-12-31-$53,665.00
2012-03-31-$20,318.00
2011-03-31$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2022-12-31-$678,838.00
2021-12-31-$986,584.00
2020-12-31-$741,590.00
2019-12-31-$2.54M$2,594.00-$2.54M
2018-12-31-$2.88M$8,969.00-$2.89M
2017-12-31-$2.99M
2016-12-31-$2.46M
2015-12-31-$1.02M$3,829.00-$1.02M
2014-12-31-$909,296.00$0.00-$909,296.00
2013-12-31-$257,416.00
2011-12-31-$50,354.00
2010-12-31$8,502.00